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Microglial cells are activated during excitotoxin-induced neurodegeneration.However, the in vivo role of micro-
glia activation in neurodegeneration has not yet been fully elucidated. To this end, we used Ikkb conditional
knockoutmice (LysM-Cre/IkkbF/F) in which the Ikkb gene is specifically deleted in cells of myeloid lineage, includ-
ing microglia, in the CNS. This deletion reduced IiB kinase (IKK) activity in cultured primary microglia by
up to 40% compared with wild-type (IkkbF/F), and lipopolysaccharide-induced proinflammatory gene expression
was also compromised. Kainic acid (KA)-induced hippocampal neuronal cell death was reduced by 30% in LysM-
Cre/IkkbF/F mice compared with wild-type mice. Reduced neuronal cell death was accompanied by decreased
KA-induced glial cell activation and subsequent expression of proinflammatory genes such as tumour necrosis
factor (TNF)-a and interleukin (IL)-1b. Similarly, neurons in organotypic hippocampal slice cultures (OHSCs)
from LysM-Cre/IkkbF/F mouse brain were less susceptible to KA-induced excitotoxicity compared with wild-
type OHSCs, due in part to decreased TNF-a and IL-1b expression. Based on these data, we concluded that
IKK/nuclear factor-iB dependent microglia activation contributes to KA-induced hippocampal neuronal cell
death in vivo through induction of inflammatory mediators.
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Abbreviations: CA1=cornu ammonis 1; CA3=cornu ammonis 3; CD11b=cluster of differentiation molecule 11b;
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IL-1b= interleukin-1b; IKK= IkB kinase; IR= immunoreactive; KA=kainic acid; LPS= lipopolysaccharide; MCAO=middle
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Introduction
Excitotoxicity is a mechanism that contributes to neuronal
cell death following acute neuronal damage, including
traumatic brain injury and stroke, and is implicated in
chronic neurodegenerative diseases (Doble, 1999). It is well
known that over-stimulation of the glutamate receptor
is responsible for excitotoxic neuronal cell death (Doble,
1999). In this process, activated microglia are easily
detected in and around the regions encompassing dying
neurons (Andersson et al., 1991b). Several studies also
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suggest that activation of microglia may contribute to
excitotoxin-induced neuronal cell death. Upon excitotoxic
brain injury, proinflammatory cytokines are expressed
by activated microglia (Barone and Feuerstein, 1999). In
another study, inhibition of microglia activation and
proliferation by a chemical inhibitor reduced excitotoxic
spinal cord neuronal cell death (Tikka et al., 2001). The
critical role of microglial production of tissue plasminogen
activator (tPA) in excitotoxin-induced hippocampal neuro-
nal cell death was also documented in a study using tPA-
deficient mice (Tsirka et al., 1995). These previous reports
support a model in which excitotoxic brain damage induces
microglial cell activation, thereby augmenting neuronal cell
death. However, it has also been argued that microglia
protect hippocampal neurons from excitotoxic cell death
(Bruce et al., 1996; Neumann et al., 2006; Simard and Rivest,
2007). In these studies, inhibition of microglial activation
by glucocorticoid augmented kainic acid (KA)-mediated
excitotoxicity, and tumour necrosis factor (TNF)-a, secreted
by activated glial cells during excitotoxic brain damage, was
found to protect hippocampal neurons from oxidative stress.
Additionally, activated microglia have been shown to release
neurotrophic factors, which promote neuronal survival
against excitotoxic neuronal damage (Elkabes et al., 1996;
Young et al., 1999). Therefore, it is conceivable that microglia
are activated to protect neurons during excitotoxic brain
damage. Thus, the in vivo role of microglial cell activation
in excitotoxic neuronal cell death is still debatable. None-
theless, in light of the in vitro neurotoxic effects of activated
microglial cells, inflammatory microglial activation is
regarded as an attractive therapeutic target for the treatment
of various neurological disorders that accompany excitotoxic
neuronal cell death (Block et al., 2007). In this regard, it is
of critical importance to elucidate the in vivo role of micro-
glia activation, as inhibitors of microglial activation could
turn out to exacerbate brain damage if microglia activation
in fact plays a neuroprotective role in vivo.
It is well known that nuclear factor-kB (NF-kB)
activation plays a critical role in the microglial production
of proinflammatory genes including TNF-a, interleukin-1b
(IL-1b) and inducible nitric oxide synthase (iNOS) (Jana
et al., 2001; Rasley et al., 2002; Moriyama et al., 2006).
Upon stimulation, NF-kB is activated by IkB kinase (IKK)
complex, in a manner dependent mainly on the IKKb
catalytic subunit (Karin, 1999). It was previously docu-
mented that NF-kB is activated in microglia in excitotoxic
brain injury (Matsuoka et al., 1999; Acarin et al., 2000).
This may account for inflammatory cytokine expression by
microglia during excitotoxic neurodegeneration. Therefore,
we reasoned that by deleting the Ikk gene in microglial
cells, we might be able to inhibit inflammatory microglia
activation. Further, by using these mice in an excitotoxic
brain injury model, we can address the in vivo role of
microglia activation in excitotoxin-induced neuronal cell
death. We tested this hypothesis by using LysM-Cre/Ikk-
floxed (LysM-Cre/IkkF/F) mice, in which the Ikk gene
was specifically deleted in cells of myeloid origin, including
the microglia in the CNS (Greten et al., 2004).
Materials and Methods
Animals and genotyping
Myeloid cell type-specific Ikk-deficient (LysM-Cre/IkkF/F) mice
were generated by breeding Ikk-floxed (IkkF/F) mice and LysM-
Cre knock-in mice expressing Cre under the control of endogenous
lysozyme M promoter as previously described (Clausen et al., 1999;
Li et al., 2003). PCR genotyping was performed using primers,
50-TGA CCC GGG AAT GAA TAG GA-30 and 50-GTC TTC AAC
CTC CCA AGC CTT-30, which amplify both the Ikk+ (220 bp) and
IkkF (310 bp) alleles. LysM-Cre mice were genotyped by PCR using
the primer pair NLS-Cre (50-CCC AAG AAG AAG AGG AAG GTG
TCC-30) and Cre8 (50-CCC AGA AAT GCC AGA TTA CG-30). Mice
were housed at 23 2C with a 12 h light–dark cycle and food
and water ad libitum. All surgical and experimental procedures
were reviewed and approved by the Institutional Animal Care and
Use Committee (IACUC) of Seoul National University.
Primary glial culture from neonates and
cortical neuron culture
Primary microglia cultures were prepared as previously described
(Lee et al., 2000). Briefly, mixed glial cultures were prepared
from postnatal day 1–3 wild-type and LysM-Cre/IkkF/F mice. After
removing meninges from the cerebral hemispheres, tissue was
dissociated into a single-cell suspension by gentle trituration. Cells
were cultured in glial culture media (DMEM supplemented with
10mM HEPES, 10% FBS, 2mM L-glutamine and 1 antibiotic/
antimycotic) in 75 cm2 flasks at 37C in a 5% CO2 incubator and
the medium was changed every 5 days. Microglia were harvested
from mixed glial cultures on day 14. After shaking at 200 r.p.m.
for 4 h on an orbital shaker, the media from the cultures was
collected and centrifuged at 800g for 10min. Microglia were plated
in glial culture media. After 30min, dishes were washed with
medium to remove unattached astrocytes. The purity of microglia
was routinely monitored and was 498% as determined by
histochemical staining with cluster of differentiation molecule
11b (CD11b) (1 : 200, Serotec Inc., Oxford, UK). After shaking on
day 14, adherent cells were trypsinized and allowed to re-attach
for 30min. Unattached astrocytes were transferred to a new plate
and cultured in glial culture medium. The purity of astrocytes
in this culture was495% by glial fibrillary acidic protein (GFAP)
(1 : 10 000; DAKO, Denmark) immunostaining, and the remaining
cells were identified as microglia or oligodendrocytes. Primary
cortical neurons were prepared from E17 mouse embryos as
previously described (Brewer et al., 1993). Microglia from adult or
neonate mouse brains were prepared as described elsewhere
(Slepko and Levi, 1996), and peritoneal macrophages (PM) were
prepared as described previously (Pfeiffer et al., 2001).
Determination of loss of the IkkbF allele at
the genomic level by real-time PCR
Genomic DNA (100 ng in 4 ml) was prepared from each sample,
and mixed with SYBR Green PCR Master Mix (10 ml, Applied
Biosystems, Foster City, CA, USA), primers (1ml at 10 mM each)
and H2O (5ml). Real-time PCR was performed for 40 cycles of
95C for 15 s and 60C for 1min using an ABI 7500 Real Time
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PCR System (Applied Biosystems, CA, USA). Primers, 50-AAG
ATG GGC AAA CTG TGA TGT G-30 and 50-CAT ACA GGC ATC
CTG CAG AAC A-30, were used to amplify the IkkF allele, and
primers, 50-GGT GCA TGG TGT GTG AAG AC-30 and 50-CAT
GCA TAC TAC CGC CAC AC-30, were used to amplify the Tnfr1
gene as a control. The ratio of Ikk and IkkF signal was
calculated after normalization to the Tnfr1 signal.
Real-time RT^ PCR
Real-time RT–PCR was performed using SYBR Green PCR Master
Mix as previously described (Lee et al., 2004). Reactions were
performed in duplicate in a total volume of 10 ml, each containing
10 pM primer, 4 ml cDNA and 5 ml SYBR Green PCR Master Mix.
The mRNA levels of each target gene were normalized to that of
GAPDH mRNA. Fold-induction was calculated using the 2CT
method as previously described (Livak and Schmittgen, 2001). All
real-time RT–PCR experiments were performed at least three
times, and the mean SEM values have been presented unless
otherwise noted. The primer sequence information can be found
in the Supplementary materials.
Stereotaxic injection and tissue processing
For intracerebroventricular (i.c.v.) injection of KA, 8- to 12-week-
old male wild-type and LysM-Cre/IkkF/F mice (22–25 g) were
anesthetized by pentobarbital sodium (30mg/kg, body weight, i.p.)
and placed on a stereotaxic apparatus (Myneurolab, MO, USA).
Animals were injected with PBS or KA (0.2 mg in 4.0 ml of PBS) at
the speed of 0.5 ml/min into the right ventricle using a 26-G needle
(stereotaxic coordinates in millimetre with reference to the
bregma: AP, 2.0; ML, 2.9; DV, 3.8). After 5min, the
needle was removed with three intermediate steps over 3min to
minimize backflow, and the incision was cleaned with saline and
sutured. Animals were kept on a warm pad until recovery. On
either day 1 or day 3 after surgery, brains were removed from the
mice after perfusion, immersed for 12 h in 4% PFA fixative at 4C
and serially cryoprotected in 10, 20 and 30% sucrose in PBS for
48 h at 4C. Serial coronal sections (30 mm thickness) were cut on
a cryostat and collected as free-floating sections in PBS. Sections
were stored at 20C until needed for histochemical studies.
Evaluating neuronal damage
For Nissl staining, hippocampal tissue sections were mounted on
gelatin-coated slides, dried for 1 day at RT and stained with 0.5%
cresyl violet. The numbers of cornu ammonis (CA) 1 and 3
neurons were counted at three levels of the dorsal hippocampus.
Specifically, alternate sections were obtained at 1.6, 1.9 and
2.2mm posterior to the bregma, and two regions from each level
(six regions for each animal) were used to count cells in the CA1
region. The number of intact neurons within the CA1 layer was
counted using a light microscope (BX51, Olympus, Japan) at
400 magnification and expressed as the number of CA1 neurons
per millimeter of linear length as described previously (Choi et al.,
2005). To maintain consistency across animals, a rectangular box
(1.0 0.25mm) was centred over the CA1 cell layer beginning
1.0mm lateral to the midline and 0.5mm medial to the CA2
subfield. Only neurons with normal visible nuclei were counted.
The mean number of CA1 neurons per millimeter of linear length
of the ipsilateral hemispheres was calculated for each treatment
group. The number of CA3 pyramidal neurons was also counted
under light microscope as described previously (Hernandez-
Sanchez et al., 2001). Cell counts were made in a defined area
(1.0mm 0.75mm) centred over the CA3 region using three
sections per brain. All assessments of histological sections were
blindly performed.
Immunohistochemistry and quantitative analysis
Immunohistochemical analysis was performed as previously
described (Park et al., 2006), and detailed methods can be
found in the Supplementary materials. To perform quantitative
analysis of CD11b and GFAP immunostaining, 3–4 sections per
animal were selected and images were captured and analysed using
MetaMorph software (Universal Imaging, PA, USA). One or two
fields (200 mm 200 mm or 100mm 100 mm) in each slide within
the midpoint of hippocampal CA1 and CA3 regions encompassing
all layers were selected for quantification, and the intensity of
CD11b and GFAP immunoreactivity was evaluated by means
of a relative optical density value. To quantify CD11b+/NG2+ cells,
images were captured under a confocal laser scanning microscopy.
The entire quantifying procedure was blindly performed.
Organotypic hippocampal slice cultures
Organotypic hippocampal slice cultures (OHSCs) were prepared
and maintained as described previously (Jung et al., 2004). After
14 days in culture, slices were exposed to 50mM KA following the
previously reported protocol (Kristensen et al., 2001). Neuronal
degeneration was quantified by the uptake of propidium iodide
(PI) into the damaged cells (Macklis and Madison, 1990). To
evaluate the effects of cytokines on KA-induced neuronal cell
death, cultures were co-treated with KA and TNF-a/IL-1b or anti-
TNF-a/IL-1b antibodies (R & D Systems, MN, USA) for 3 h, and
then, incubated in recovery medium for 24 h with or without
cytokines or blocking antibodies. Detailed methods can be found
in the Supplementary materials.
Hippocampal EEG analysis
Methods for hippocampal electroencephalography (EEG) after KA
injection are presented in Supplementary materials.
Transient middle cerebral artery occlusion
Transient Middle Cerebral Artery Occlusion (MCAO) was per-
formed as previously described (Kim et al., 2004). Detailed
methods can be found in the Supplementary materials.
Statistical analysis
The statistical significance of the differences between wild-type and
LysM-Cre/IkkF/F mice was determined by Student’s t-test or
ANOVA with a Fisher’s post hoc test. All data are presented as
mean SEM. Differences were considered significant when P50.05.
Results
The Ikkb gene is deleted in microglial cells
of LysM-Cre/IkkbF/F mice
Previously, we reported that the Ikk gene is tissue-
specifically deleted in myeloid cells of LysM-Cre/IkkF/F
mice, in which the Cre transgene is constitutively expressed in
cells of myeloid origin (Park et al., 2002; Greten et al., 2004).
Role of microglial IKKb in neuronal death Brain (2008), 131, 3019^3033 3021
Since microglia belong to the myeloid lineage, have
characteristics of macrophages/monocytes and constitutively
express the lysozyme gene (Perry et al., 1985; Zucker-Franklin
et al., 1987; Hao et al., 1991), we tested whether Ikk is deleted
in microglial cells of LysM-Cre/IkkF/F mice. First, we
cultured primary microglial cells from neonatal LysM-Cre/
IkkF/F mice and measured the Ikk deletion rate at the
genomic level with real-time PCR using a specific primer set
designed to detect undeleted-Ikk alleles, as previously
described (Li et al., 2003). In cultured primary microglia of
LysM-Cre/IkkF/F mice, 36 3% of the Ikk alleles in the
population were deleted, while deletion of Ikk was not
detected in primary cortical neurons (Fig. 1B). In primary
cultured astrocytes, the deletion frequency was only 3 1%,
probably due to contamination of the astrocyte culture with
microglia (Fig. 1B). We then tested whether deletion of Ikk
in microglia correlates with reduced IKK activity using an
in vitro kinase assay. Lipopolysaccharide (LPS)-stimulated IKK
activity in primary microglial cells from LysM-Cre/IkkF/F
mice was decreased by 40% compared with IKK activity in
wild-type (IkkF/F) microglia (Fig. 1C). These results suggest
that 40% of the microglial cells lost Ikk alleles. Similarly,
LPS-induced expression of proinflammatory genes such as
TNF-a, IL-1b, iNOS, intercellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)
was decreased by 30–60% (Fig. 1D). These data demonstrate
that cultured microglial cells from LysM-Cre/IkkF/F mice are
less responsive to LPS stimulation. Since microglial cell
cultures are derived from neonates, it is possible that the
deletion rate may not represent the Ikk deletion rate in adult
mice in vivo. To test this, we harvested microglial cells directly
from adult mice using a previously reported procedure
(Slepko and Levi, 1996) and assessed the Ikk deletion rate.
In microglia directly isolated from 8-week-old adult LysM-
Cre/IkkF/F cerebra, only 4% of the Ikk alleles were deleted,
although we observed 71 2% Ikk deletion in PM
(Fig. 1E), which is consistent with a previous study (Greten
et al., 2004). The Ikk deletion rate in the microglia
population directly isolated from neonate mice cerebra was
20% (data not shown), which is higher than the deletion
rate in adult mouse microglia in vivo, but still lower than the
rate in primary cultured microglia. These results show that
Ikk is more easily deleted in primary cultured microglia,
which are in a more activated state than microglia in vivo
(Eder et al., 1999; Hurley et al., 1999), and implies that the
in vivo Ikk deletion rate may be increased upon microglia
activation. To test this, we stimulated LysM-Cre/IkkF/F
microglia in vivo by i.c.v. LPS injection. One day after LPS
injection, in microglia isolated from the whole cerebrum, the
Ikk deletion rate increased to 31 2% and injection of KA
increased the Ikk deletion rate to 20 3% (Fig. 1E). In
microglia isolated from the hippocampus, where KA-induced
microglial activation is most prominent, the deletion rate
increased to 73 2% (Fig. 1E). Taken together, these data
show that KA-injection enhances microglia-specific Ikk
deletion in LysM-Cre/IkkF/F mice, and suggest that microglia
in LysM-Cre/IkkF/F mice are less responsive to inflammatory
or stress stimulation.
KA-induced death of hippocampal neurons
is reduced in LysM-Cre/IkkbF/F mice
To determine the in vivo role of IKKb-mediated microglial
cell activation in excitotoxin-induced hippocampal neuro-
nal cell death, we introduced KA directly into the brains
of wild-type and LysM-Cre/IkkF/F mice. The i.c.v. KA
introduction is a well-established excitotoxicity model that
induces behavioural manifestations of seizures in mice and
selective hippocampal cell death (Cho et al., 2003). We did
not observe any discernible differences between wild-type
and LysM-Cre/IkkF/F mice in terms of seizure-like behav-
iour or hippocampal EEG analysis [power spectrum main
frequency range, 1 day after KA injection: 0.5–3Hz in wild-
type mice (n= 5) versus 0.7–1.7Hz in LysM-Cre/IkkF/F
mice (n= 4); 3 days after KA injection: 0.5–2Hz in wild-
type mice (n= 5) versus 0.5–2Hz in LysM-Cre/IkkF/F mice
(n= 4)]. Hippocampal neuronal cell death was measured by
cresyl violet staining. After KA administration, a character-
istic loss of pyramidal neurons in the CA1 and CA3
subfields of the ipsilateral hippocampus was observed in
wild-type mice (Fig. 2C and D), whereas no obvious
neuronal loss was observed in the ipsilateral hippocampus
of PBS-injected wild-type mice (Fig. 2A and B). The extent
of hippocampal neuronal loss was significantly reduced in
LysM-Cre/IkkF/F mice (Fig. 2E and F). Three days after KA
injection, the number of live neuronal cells in the CA1 and
CA3 subfields of wild-type mice decreased by 58% and 76%,
respectively, whereas in LysM-Cre/IkkF/F mice, live neuronal
cells in the CA1 and CA3 areas were reduced by only 38%
and 60%, respectively (Fig. 2G). Comparable levels of neu-
ronal loss were obtained by counting neuronal cells by
immunohistochemistry using anti-NeuN antibody (data not
shown). Interestingly, however, the reduction in neuronal
loss in LysM-Cre/IkkF/F mice compared with wild-type mice
was not prominent 1 day after KA injection (Fig. 2G).
KA-induced glial cell activation is reduced
in LysM-Cre/IkkbF/F mice
To assess the effects of Ikk deletion on KA-treated
hippocampal glial cells, activation of microglia and astro-
cytes was analysed by immunohistochemistry using anti-
Iba-1 and anti-GFAP antibodies, respectively (Figs 3 and 4).
In PBS-treated wild-type mice, ionized calcium binding
adaptor molecule-1 (Iba-1)-immunoreactive (IR) microglia
were in their resting form (Fig. 3A–C). In KA-injected
wild-type mice, along with hippocampal neuronal loss, the
number of Iba-1-IR cells was remarkably increased in
both the CA1 and CA3 regions of the ipsilateral hippo-
campus (Fig. 3D–F). Iba-1-IR microglia showed activated
cell morphology, with enlarged cell bodies and thicker
processes. In KA-injected LysM-Cre/IkkF/F mice, however,
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microglia activation was notably suppressed. There were
fewer Iba-1-IR cells, and their morphology was more
ramified (Fig. 3G–I). Quantitatively, Iba-1 expression was
decreased by 30% (Fig. 3J). The suppression of microglial
activation in LysM-Cre/IkkF/F mice was also confirmed by
measuring the CD11b mRNA levels (Fig. 3K). The extent
of microglial activation in the hippocampus was well
correlated with the rate of neuronal loss in the adjacent
Fig. 1 Microglia-specific Ikk gene deletion in the LysM-Cre/IkkF/F mice. (A and B) Primary microglia and astrocytes were cultured
from neonatal wild-type (IkkF/F) or LysM-Cre/IkkF/F mice, and cortical neurons were isolated and cultured from E17 embryos of
LysM-Cre/IkkF/F mice.Genomic DNA from each primary cell culture was analysed by real-time PCR to determine the rate of Ikk
deletion (A). Percentages of undeleted and deleted IkkF alleles are shown in black and grey bars, respectively (B). (C) Primary microglia
from wild-type and LysM-Cre/IkkF/F mice were stimulated with LPS (10ng/ml) for 30min, and cell lysates were used to measure IKK
activity. Samples were resolved on SDS^PAGE, and radiolabelled substrates were exposed using a PhosphorImager (upper panel).
The same membrane was probed with anti-IKKa antibody to normalize IKK loading (lower panel). (D) Primary microglia from either
wild-type (black bars) or LysM-Cre/IkkF/F mice (grey bars) were stimulated with LPS (10ng/ml) for 3h.Total RNAwas prepared and
used to determine the mRNA expression levels of TNF-a, IL-1b, iNOS, ICAM-1 and VCAM-1, which are represented as fold-induction.
(E) Microglia and PM from adult wild-type or LysM-Cre/IkkF/F mice were used to prepare genomic DNA to determine the Ikk gene
deletion rate. Percentages of undeleted and deleted IkkF alleles are shown in black and grey bars, respectively.
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region (data not shown). Similarly, astrocyte activation in the
ipsilateral hippocampus after KA-treatment was also attenu-
ated in LysM-Cre/IkkF/F mice compared with wild-type
mice (Fig. 4A–K). These results show that microglia-specific
Ikk deletion suppresses KA-induced microglia activation
in the hippocampus in vivo and that microglia activation
may influence astrocyte activation.
Microglial IKKb deletion is responsible
for the attenuation of KA-induced
hippocampal neuronal cell death
Our results from LysM-Cre/IkkF/F mice suggest that
microglia-specific Ikk deletion decreases KA-induced
hippocampal neuronal cell death. However, they do not
Fig. 2 KA-induced hippocampal neuronal cell death is decreased in LysM-Cre/IkkF/F mice.Wild-type (IkkF/F) (A^D) and LysM-Cre/IkkF/F
(E and F) mice were i.c.v. injected with either PBS (A and B) or KA (0.2mg in 4ml PBS) (C^F). Cryosections (30mm thick) were stained
with cresyl violet. Arrows indicate dying neurons and arrow heads show live cells. Scale bars: 50mm. (G) The rate of neuronal loss in
the CA1 or CA3 area of ipsilateral side hippocampus was evaluated by counting live cells. Data are presented as mean SEM. (Student’s
t-test, P50.05, P50.01; versus wild-type mice.)
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rule out the possibility that other myeloid cells such
as macrophages or neutrophils from the periphery are
involved, since the Ikk gene is also deleted in these cell
types (Greten et al., 2004). To test this possibility, we
examined macrophage and neutrophil infiltration of the
brain parenchyma following KA treatment. For macrophage
detection, we used antibodies for neuron-glial antigen
2 (NG2) and CD11b. It has been previously reported
that blood-derived macrophages are double-positive for
NG2 and CD11b, while oligodendrocyte precursor cells are
single-positive for NG2 (Bu et al., 2001; Jones et al., 2002).
A subpopulation of CD11b-IR cells co-expressing NG2
(CD11b+/NG2+) was detected in the ipsilateral hippocam-
pus of KA-injected wild-type mice (Fig. 5A–C), whereas
no obvious CD11b+/NG2+ cells were observed in the PBS-
injected ipsilateral hippocampus or KA-injected contral-
ateral hippocampus (data not shown). Interestingly, the
number of CD11b+/NG2+ cells was slightly reduced in
the LysM-Cre/IkkF/F mice (3.8 0.7/field) compared with
the wild-type mice (5.3 0.5/field), though this was not
statistically significant (Fig. 5D). In addition, we did not
observe significant neutrophil infiltration in hippocampal
parenchyma in either control or LysM-Cre/IkkF/F mice
after KA injection (data not shown), which is consistent
Fig. 3 KA-induced microglia activation is reduced in LysM-Cre/IkkF/F mice.Wild-type (IkkF/F) (A^F) and LysM-Cre/IkkF/F (G^I) mice
were i.c.v. injected with either PBS (A^C) or KA (D^I). After 3 days, mice were sacrificed and cryosections were immunostained
with anti-Iba-1 (A^I) antibodies. P: pyramidal cell layer. Scale bars: 100mm. (J) Expression levels of Iba-1 in the CA1 and CA3 subfields
of wild-type and LysM-Cre/IkkF/F mice were quantified. (K) The mRNA levels of CD11b in the ipsilateral hippocampus were
examined 36h after KA injection. Data are presented as mean SEM. (Student’s t-test, P50.05, P50.01; versus wild-type mice.)
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with findings from a previous report (Andersson et al.,
1991a). These data suggest that it is not likely that reduced
KA-induced neuronal loss in LysM-Cre/IkkF/F mice is due
to a reduction in myeloid cell infiltration in these mice.
To further exclude the contribution of blood-derived
macrophages or neutrophils, we adopted an OHSC system,
and tested the effects of Ikk deletion in microglia on
excitotoxicity ex vivo. Hippocampal slices from wild-type
and LysM-Cre/IkkF/F mice were maintained in culture
medium for 2 weeks prior to KA stimulation to eliminate
any blood-derived macrophages or neutrophils (Fig. 6A).
Stimulated cultures were evaluated using cellular uptake of
PI as a measure of excitotoxic neuronal damage.
Immediately after a 3 h exposure to KA (0 h of recovery),
the fluorescence values of PI uptake in the CA1 and
CA3 areas were slightly increased to 21.1 3.2% and
11.5 2.7%, respectively, in wild-type OHSCs, and similar
levels of PI uptake were detected in the LysM-Cre/IkkF/F
OHSCs (Fig. 6D, E, H and I). Upon 24 h recovery after KA
exposure, PI uptake in the CA1 and CA3 regions of wild-
type OHSCs was further increased to 42.5 5.5% and
25.5 4.7%, respectively. However, in OHSCs from LysM-
Cre/IkkF/F mice, the increase in PI uptake during the
recovery period was significantly attenuated compared
Fig. 4 KA-induced astrocyte activation is reduced in LysM-Cre/IkkF/F mice.Wild-type (IkkF/F) (A^F) and LysM-Cre/IkkF/F (G^I) mice
were i.c.v. injected with either PBS (A^C) or KA (D^I). After 3 days, mice were sacrificed and cryosections were immunostained with
anti-GFAP (A^I) antibodies. P: pyramidal cell layer. Scale bars: 100mm. (J) Expression levels of GFAP in the CA1 and CA3 subfields of
wild-type and LysM-Cre/IkkF/F mice were quantified. (K) The mRNA levels of GFAP in the ipsilateral hippocampus were examined
36h after KA injection. Data are presented as mean SEM. (Student’s t-test, P50.05, P50.01; versus wild-type mice.)
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with wild-type: it increased to only 25.6 3.6% and
17.1 2.6%, respectively (Fig. 6F–I). In control OHSCs,
however, a slightly higher level of basal PI uptake was
detected in slices from LysM-Cre/IkkF/F mice. Taken
together, these data argue that Ikk deletion in microglia
is responsible for the attenuation of KA-induced hippo-
campal neuronal cell death and that the IKKb/NF-kB
signalling pathway in microglia may play an important role
in KA-induced excitotoxicity in the hippocampus.
KA-induced proinflammatory
gene expression is reduced
in LysM-Cre/IkkbF/F mice
In an attempt to elucidate the mechanisms underlying the
difference in excitotoxic susceptibility of wild-type and
LysM-Cre/IkkF/F mice, we measured the mRNA expres-
sion levels of proinflammatory NF-kB-target genes such as
TNF-a, IL-1b and iNOS in the hippocampus. These genes
have been implicated in excitotoxic hippocampal neuronal
cell death (De Simoni et al., 2000; Rizzi et al., 2003). The
mRNA levels of TNF-a, IL-1b and iNOS in the hippocampi
of KA-stimulated wild-type mice increased 12-, 35- and
3-fold, respectively (Fig. 7). KA-induced expression of these
proinflammatory genes in hippocampi of LysM-Cre/IkkF/F
mice, however, was attenuated by 30–50%. These data
demonstrate that KA-induced inflammatory gene expres-
sion is reduced in LysM-Cre/IkkF/F mice.
TNF-a and IL-1b contribute to KA-induced
hippocampal cell death in OHSCs
We then tested the effects of proinflammatory cytokines on
excitotoxicity in OHSCs (Fig. 8). Treatment of KA-stimulated
LysM-Cre/IkkF/F OHSCs with TNF-a (10–40 ng/ml in CA1;
20 ng/ml in CA3) completely elevated the cell death rate to the
level seen in wild-type OHSCs (Fig. 8B). Likewise, treatment
with IL-1b (0.1–10 ng/ml in CA1; 5–10 ng/ml in CA3)
enhanced the KA-mediated excitotoxicity in LysM-Cre/
IkkF/F OHSCs (Fig. 8C). The specificity of the cytokines
was confirmed using blocking antibodies against TNF-a and
IL-1b in this experiment (data not shown). Furthermore, the
addition of anti-TNF-a or anti-IL-1b blocking antibodies in
the wild-type OHSCs reduced KA-mediated excitotoxicity by
30–60% (Fig. 8B and C). Taken together, these data suggest
that TNF-a and IL-1b expression in wild-type OHSCs
potentiates KA excitotoxicity, and that decreased expression
of these cytokines in LysM-Cre/IkkF/F OHSCs partly
accounts for the decreased KA excitotoxicity.
Ischaemic brain damage and microglia
activation after transient MCAO
is reduced in LysM-Cre/IkkbF/F mice
To verify the neuroprotective effects of microglial Ikk
deletion in a more physiologically relevant disease model,
we induced ischaemic brain damage by MCAO in
Fig. 5 Microglial IKK deletion does not block immune cell recruitment from the periphery. (A^C) Infiltration of peripheral monocytes
in the ipsilateral hippocampus was examined by immunostaining with anti-CD11b and anti-NG2 antibodies 3 days after KA injection in
wild-type and LysM-Cre/IkkF/F mice. Scale bars: 50mm. (D) CD11b+/NG2+ cells were counted in 27 optical fields (350mm 350mm) per
animal group (two fields per section, two sections per animal in the seven animals per group). Data are expressed as mean SEM.
(Student’s t-test, P=0.09; versus wild-type mice.)
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LysM-Cre/IkkF/F mice. It is well known that excitotoxicity
is one of the underlying mechanisms of ischaemic neuro-
degeneration (Doble, 1999). A 1-h MCAO followed by a
3-day reperfusion period induced 40% degeneration of
the ipsilateral brain, as calculated by infarct volume
(Fig. 9A and B). In LysM-Cre/IkkF/F mice, however, the
infarct size decreased to 510%. We then tested microglia
activation after MCAO by Iba-1 immunostaining. As
previously reported (Schilling et al., 2003), ischaemic
injury induced microglia activation around the infarct
region in wild-type mice (Fig. 9C). The levels of microglia
activation were variable depending on the distance to the
infarct region: the closer to the infarct region, the stronger
the microglia activation (Fig. 9C, compare A and B).
Microglia activation was also detected in LysM-Cre/IkkF/F
mice. However, the activation levels were much weaker
than those of wild-type mice (Fig. 9C, compare upper
panels versus lower panels). These data demonstrate that
Fig. 6 Neurons in OHSCs from LysM-Cre/IkkF/F mice are less susceptible to KA-induced excitotoxicity. (A) Schematic representation of
the protocols used to study KA excitotoxicity in OHSCs.OHSCs were maintained in slice culture medium for 2 weeks, then exposed to
KA (50mM) for 3h. After a media change, OHSCs were either directly fixed (D and E), or allowed to recover in fresh media for 24h
before fixation (F and G). One hour prior to fixation, PI (0.2 mg/ml) was added to the media. Neuronal cell death in OHSCs was deter-
mined by PI uptake in the CA1 and CA3 pyramidal cell layers. The extent of neuronal degeneration was quantified by PI fluorescence
intensity (H and I), and representative images are shown (B^G). Scale bars: 200mm. Data are presented as mean SEM. (ANOVA test
with a Fisher’s post hoc test, P50.01, versus control wild-type OHSCs;+P50.05, ++P50.01, versus control LysM-Cre/IkkF/F OHSCs;
#P50.05, ##P50.01, versus KA-treated wild-type OHSCs.)
Fig. 7 KA-induced proinflammatory gene expression is reduced in
LysM-Cre/IkkF/F mice.Wild-type and LysM-Cre/IkkF/F mice were
i.c.v. injected with KA or PBS. After 36h, total RNAwas prepared
from ipsilateral hippocampus and used for quantitative real-time
PCR to measureTNF-a, IL-1b and iNOS mRNA levels. The relative
mRNA expression levels in KA-injectedmice compared with those
in PBS-injected mice are presented as fold induction (P50.01 by
Student’s t-test; versus wild-type mice; n45).
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LysM-Cre/IkkF/F mice are less susceptible to MCAO-
induced ischaemic brain damage and microglia activation.
Discussion
To address the in vivo role of inflammatory microglia
activation in excitotoxicity, we employed myeloid cell type-
specific Ikk conditional knockout (LysM-Cre/IkkF/F)
mice. In primary cultured microglia from neonate LysM-
Cre/IkkF/F mice, we found that the Ikk deletion frequency
was 36%, but the deletion frequency in microglia isolated
directly from adult or neonate LysM-Cre/IkkF/F mice was
much lower. This difference may be due to the fact that
microglia are in their resting state in vivo and then become
spontaneously activated during in vitro culture, resulting in
upregulation of the lysozyme M gene (Ohmi et al., 2003).
This explanation accounts for the increase in the Ikk
deletion rate to 73% in microglia from KA-treated LysM-
Cre/IkkF/F ipsilateral hippocampus (Fig. 1E). Interestingly,
we detected a higher microglial Ikk deletion frequency in
neonate mice compared with adult mice. This implies that
lysozyme M gene expression is developmentally regulated in
microglia, which may also contribute to the enhanced Ikk
deletion frequency observed in the primary cultured
microglia. In addition, our in vitro data demonstrate that
the Ikk gene is deleted in microglia, but not in astrocytes
or in neurons of the LysM-Cre/IkkF/F brain and, in the
absence of IKKb in microglia, IKKb/NF-kB-dependent
inflammatory gene expression is attenuated. These data
argue that LysM-Cre/IkkF/F mice can be used to investigate
the in vivo role of microglia activation in excitotoxic
neurodegeneration.
Fig. 8 Treatment withTNF-a and IL-1b potentiates KA-induced excitotoxicity in OHSCs from LysM-Cre/IkkF/F mice. (A) Schematic
representation of the protocols used to study the effects of TNF-a or IL-1b on KA-induced neuronal cell death in OHSCs. LysM-Cre/IkkF/F
OHSCs were co-treated with KA (50mM) and cytokines for 3h, then incubated in recovery medium with or without various concentra-
tions of TNF-a (B) or IL-1b (C). In addition, wild-type OHSCs were treated with KA, in the presence or absence of either anti-TNF-a
(B) or anti-IL-1b (C) blocking antibodies. After 24h of recovery, OHSCs were fixed and cellular PI uptake was measured in the CA1
and CA3 pyramidal cell layers. The extent of neuronal degeneration was quantified by fluorescence intensity of PI (B and C). Data are
expressed as mean SEM. (ANOVA test with a Fisher’s post hoc test; P50.05, P50.01; versus KA-treated LysM-Cre/IkkF/F OHSCs.)
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It should be noted that, in these mice, only partial deletion
(73% maximum) of the IkkF allele in the KA-activated
hippocampal microglia population was achieved. The
incomplete deletion of the IkkF allele in the entire popu-
lation of microglial cells resembles the situation in mac-
rophages, where the IkkF deletion rate rarely exceeded 75%
in bone marrow-derived macrophages from LysM-Cre/
IkkF/F mice (Greten et al., 2004). The incomplete deletion
of a target gene is often a drawback of using tissue-specific
conditional knockout mice. Although a study using conven-
tional knockout mice does not face such problems, it does
not provide researchers with cell type-specific information
either. Indeed, it was reported that p50 knockout mice
are more vulnerable to KA-induced excitotoxicity, indicat-
ing a beneficial role of NF-kB activation in these mice
(Yu et al., 1999). However, such effects were attributed
mainly to NF-kB activation in neurons, but not in microglia.
Similarly, the neuroprotective function of microglial activa-
tion was suggested in a recent study using MyD88 knockout
mice (Simard and Rivest, 2007), in which the effects of
MyD88 deletion in microglia versus non-microglial cells
could not be differentiated. Our in vivo data, however,
indicate that IKKb deletion in microglia exerts protective
effects against KA-induced excitotoxic hippocampal neuronal
cell death. Thus far, several reports have suggested a neu-
rotoxic role of microglia in excitotoxicity. However, most
of these studies are based on circumstantial evidence sup-
ported by in vitro experiments using cultured microglia.
In this regard, our study using Ikk conditional knockout
mice, conclusively demonstrates the in vivo role of the
IKK/NF-kB-mediated microglia activation in excitotoxicity.
Interestingly, the attenuation of excitotoxicity in LysM-
Cre/IkkF/F mice was not statistically significant 1 day
after injection, but was substantial 3 days after i.c.v.
Fig. 9 Infarct size and microglial activation following MCAO are reduced in LysM-Cre/IkkF/F mice.Wild-type and LysM-Cre/IkkF/F mice
were subjected to transient MCAO for1h and reperfused. (A) After 71h, the brains were removed, cut into 2-mm thick blocks and stained
with triphenyl tetrazolium chloride. (B) The infarct area was measured and expressed as the percentage of the ipsilateral hemisphere.
Data are presented as mean SEM. (P50.001 by Student’s t-test; versus wild-type mice; n=4). (C) Cryosections of the second blocks
were stained with anti-Iba-1 antibody. Representative images of five different regions were captured and are presented (ipsilateral: a^ d,
contralateral: e). Scale bars: 50 mm.
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administration of KA (Fig. 2). It has been reported that
introduction of KA into the brain induces excitotoxicity
through two different mechanisms. Primary hippocampal
damage is induced within 24 h by KA-mediated seizure
activity, while further delayed neuronal cell death follows
this initial damage after 2–3 days (Doble, 1999). The
absence of any significant difference in terms of hippo-
campal EEG activity argues against that reduced neuronal
death in the knockout mice is due to reduced seizures in
these mice. Rather, our data suggest that IKKb-mediated
microglia activation contributes to delayed excitotoxic
neurodegeneration in the later stage. These results are
consistent with those of previous reports showing that
inflammatory mediators contribute to excitotoxic neurode-
generation at later stages (Giulian and Vaca, 1993).
Notably, we observed attenuation of glial cell activation
not only in microglia, but also in astrocytes of LysM-Cre/
IkkF/F mice (Fig. 4A–K). Considering that Ikk is deleted
only in microglia, it is likely that KA-induced astrocyte
activation is secondary to microglia activation.
Thus far, it is not clear how microglia become activated
upon KA stimulation. Although direct microglial activation
by KA has been reported (Noda et al., 2000), we were not
able to detect any proinflammatory gene expression after
KA treatment of cultured hippocampal glial cells (data not
shown). Therefore, it is more likely that microglia are
indirectly activated by KA-damaged neurons. In this regard,
it is of interest that high-mobility group box-1 (HMGB-1),
a non-histone DNA-binding protein, was recently reported
to be released by damaged neurons in the ischaemic brain,
thus activating microglia (Kim et al., 2006). It has also been
documented that HMGB-1 exerts its cytokine-like function
by activating toll-like receptor (TLR) 2 and 4 on innate
immune cells (Park et al., 2004). In the CNS, TLR2 and 4
are constitutively expressed on microglia (Olson and Miller,
2004). Considering that IKK/NF-kB activation is a major
downstream signal of TLR, it is tempting to speculate that,
in our excitotoxicity model, microglia are activated by TLR
binding to HMGB-1 released from KA-damaged hippo-
campal neurons. This can be addressed in future studies
using TLR2- or 4-deficient mice.
It should be noted that, in this study, we did not find
direct in vivo evidence that the reduction in neuronal loss
in the knockout mice was due to IKKb deletion in
microglia, since IKKb in these mice was also deleted in
other myeloid lineage cells. However, indirect evidence
suggests microglia-specific effects on excitotoxicity. First, in
immunohistochemistry tests, we did not observe a statis-
tically significant reduction in macrophage infiltration
in LysM-Cre/IkkF/F mice after KA administration. More
importantly, neurons in OHSCs from LysM-Cre/IkkF/F
mice were relatively resistant to the KA-induced excito-
toxicity. In such an OHSC model, the effects of blood-
derived myeloid cells were minimized, since hippocampal
slices were cultured in vitro without blood supply for
2 weeks before the experiment. Considering these data,
we concluded that microglia-specific IKKb deletion plays
a major role in the attenuation of excitotoxicity.
In ex vivo experiments, excitotoxic hippocampal cell
death was reduced by 30–40% in the OHSCs of LysM-Cre/
IkkF/F mice, which is reminiscent of the reduction rate
in vivo. However, the kinetics of the cell death were
dissimilar. In the in vivo system, we did not observe a
statistically significant difference in the cell death rate
between wild-type and LysM-Cre/IkkF/F mice 24 h after
KA injection, whereas in OHSCs, the decrease in cell death
was prominent after 24 h of recovery (Figs 2 and 6). This
can be simply attributed to the temporal difference in KA
accessibility to hippocampal neurons in vivo versus ex vivo.
Alternatively, this can be explained by the difference in the
deletion rate of Ikk at the time of stimulation. Since
hippocampal slices were prepared from neonate mice, it
is likely that the microglial Ikk deletion rate of OHSCs
is higher than the in vivo rate of adult mice, which may
account for the difference.
To elucidate the basis of neurotoxic effects of IKKb
activation, we monitored the expression of several putative
neurotoxic mediators that can be induced upon IKKb
activation in microglia. KA-induced TNF-a, IL-1b and
iNOS gene expression was reduced in the ipsilateral hippo-
campus of LysM-Cre/IkkF/F mice (Fig. 7). In addition,
exogenous addition of TNF-a and IL-1b to LysM-Cre/
IkkF/F OHSCs enhanced their excitotoxic susceptibility
(Fig. 8). These data imply that IKKb-dependent expression
of these inflammatory cytokines may be, at least in part,
responsible for the delayed excitotoxicity. The neurotoxic
effects of IL-1b and iNOS in excitotoxicity are well
documented (Hara et al., 1997). Likewise, TNF-a has
been implicated as a critical mediator of neuronal cell death
in cerebral ischaemia (Meistrell et al., 1997). However, it
has also been reported that TNF-a expression during
excitotoxic damage plays a neuroprotective role (Cheng
et al., 1994). Furthermore, TNF receptor-deficient mice are
more susceptible to excitotoxic brain injury, which also
suggests a neuroprotective role of TNF-a in vivo (Bruce
et al., 1996). Thus far, there is no clear explanation for
these discrepancies. It should be noted, however, that
the TNF receptor gene is deleted in all brain cells of the
knockout mice, including neurons and glia, from early
development. In LysM-Cre/IkkF/F mice, however, TNF-a
production is altered only in microglia and only after
excitotoxic brain injury, which may account for the dif-
ferent results. Moreover, deletion of microglial Ikk
reduced the expression of other inflammatory mediators.
Therefore, the neurotoxic effects of microglial activation
might be due to the concerted effects of various IKKb
target genes. In our study, we measured expression of
proinflammatory cytokines in vivo, but confirmed their
neurotoxic effects ex vivo using OHSCs. Therefore, it is
formally possible that another IKKb-dependent gene not
tested in this study contributes to delayed neuronal cell
death in vivo. For instance, microglial production of tPA
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has been proposed as a major player in delayed type
excitotoxicity. However, in our system, there were no
significant differences in mRNA expression of this gene
after KA stimulation between wild-type and LysM-Cre/
IkkF/F mice (data not shown).
Finally, our data from MCAO model suggest that the
neuroprotective role of microglial Ikk deletion is involved
in a more physiological neurodegeneration. Interestingly,
the attenuation rate of brain damage in LysM-Cre/IkkF/F
mice in a MCAO model was much higher than in a
KA-excitotoxicity model. It has been documented that
peripheral immune cells such as macrophages and neutro-
phils infiltrate the brain parenchyma after ischaemic brain
injury, which contributes to neurodegeneration (Schroeter
et al., 1994; Villa et al., 2007). In LysM-Cre/IkkF/F mice, Ikk
is also deleted in monocytes and neutrophils (Greten et al.,
2004). Therefore, it is possible that the decrease in infarct
size in LysM-Cre/IkkF/F mice is not only due to microglial
Ikk deletion, but also to Ikk deletion in peripheral immune
cells, which may account for the difference in the inhibi-
tion rate between ischaemic injury versus KA-excitotoxicity.
In this study, we did not delve further into the relative
contribution of the Ikk deletion in peripheral immune cells
versus microglia in the MCAO model.
In summary, we demonstrated, in this study, that
microglia-specific IKKb activation potentiates KA-induced
excitotoxic hippocampal neuronal cell death. These results
suggest that IKKb-dependent inflammatory cytokine
expression in microglia contributes to the potentiation of
excitotoxic injury.
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